Product
QVM149
Aliases
Placebo to QVM149
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.Status: Not yet recruiting, Estimated PCD: 2026-03-18